Literature DB >> 20130212

Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression.

Guangwen Ren1, Xin Zhao, Liying Zhang, Jimin Zhang, Andrew L'Huillier, Weifang Ling, Arthur I Roberts, Anh D Le, Songtao Shi, Changshun Shao, Yufang Shi.   

Abstract

Cell-cell adhesion mediated by ICAM-1 and VCAM-1 is critical for T cell activation and leukocyte recruitment to the inflammation site and, therefore, plays an important role in evoking effective immune responses. However, we found that ICAM-1 and VCAM-1 were critical for mesenchymal stem cell (MSC)-mediated immunosuppression. When MSCs were cocultured with T cells in the presence of T cell Ag receptor activation, they significantly upregulated the adhesive capability of T cells due to the increased expression of ICAM-1 and VCAM-1. By comparing the immunosuppressive effect of MSCs toward various subtypes of T cells and the expression of these adhesion molecules, we found that the greater expression of ICAM-1 and VCAM-1 by MSCs, the greater the immunosuppressive capacity that they exhibited. Furthermore, ICAM-1 and VCAM-1 were found to be inducible by the concomitant presence of IFN-gamma and inflammatory cytokines (TNF-alpha or IL-1). Finally, MSC-mediated immunosuppression was significantly reversed in vitro and in vivo when the adhesion molecules were genetically deleted or functionally blocked, which corroborated the importance of cell-cell contact in immunosuppression by MSCs. Taken together, these findings reveal a novel function of adhesion molecules in immunoregulation by MSCs and provide new insights for the clinical studies of antiadhesion therapies in various immune disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130212      PMCID: PMC2881946          DOI: 10.4049/jimmunol.0902023

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms.

Authors:  Vincent F M Segers; Ivan Van Riet; Luc J Andries; Katrien Lemmens; Marc J Demolder; Ann J M L De Becker; Mark M Kockx; Gilles W De Keulenaer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-21       Impact factor: 4.733

2.  Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes.

Authors:  Monique E Quaedackers; Carla C Baan; Willem Weimar; Martin J Hoogduijn
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

Review 3.  Endothelial-leukocyte adhesion molecules.

Authors:  M P Bevilacqua
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

4.  Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

Authors:  Kazuya Sato; Katsutoshi Ozaki; Iekuni Oh; Akiko Meguro; Keiko Hatanaka; Tadashi Nagai; Kazuo Muroi; Keiya Ozawa
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

5.  Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis.

Authors:  J W Rose; C T Welsh; K E Hill; M K Houtchens; R S Fujinami; J J Townsend
Journal:  J Neuroimmunol       Date:  1999-06-01       Impact factor: 3.478

6.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

Review 7.  Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease.

Authors:  Holger Ulbrich; Einar E Eriksson; Lennart Lindbom
Journal:  Trends Pharmacol Sci       Date:  2003-12       Impact factor: 14.819

8.  Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.

Authors:  B R Yacyshyn; W Y Chey; J Goff; B Salzberg; R Baerg; A L Buchman; J Tami; R Yu; E Gibiansky; W R Shanahan
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma.

Authors:  Gail M Gauvreau; Allan B Becker; Louis-Philippe Boulet; Jamila Chakir; Robert B Fick; William L Greene; Kieran J Killian; Paul M O'byrne; John K Reid; Donald W Cockcroft
Journal:  J Allergy Clin Immunol       Date:  2003-08       Impact factor: 10.793

10.  Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

Authors:  Guangwen Ren; Juanjuan Su; Liying Zhang; Xin Zhao; Weifang Ling; Andrew L'huillie; Jimin Zhang; Yongqing Lu; Arthur I Roberts; Weizhi Ji; Huatang Zhang; Arnold B Rabson; Yufang Shi
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

View more
  233 in total

1.  Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.

Authors:  Jeffery J Auletta; Robert J Deans; Amelia M Bartholomew
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

2.  Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells.

Authors:  M J Crop; C C Baan; S S Korevaar; J N M Ijzermans; M Pescatori; A P Stubbs; W F J van Ijcken; M H Dahlke; E Eggenhofer; W Weimar; M J Hoogduijn
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

Review 3.  Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Authors:  Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo Giannuzzi; Felicia Farina; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

4.  Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties.

Authors:  Thomas J Bartosh; Joni H Ylöstalo; Arezoo Mohammadipoor; Nikolay Bazhanov; Katie Coble; Kent Claypool; Ryang Hwa Lee; Hosoon Choi; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

5.  Astragaloside IV Inhibits the Inflammatory Injury of Chicken Type II Pneumocytes Induced by Avian Pathogenic Escherichia coli.

Authors:  Li-Yan Zhang; Peng-Fei Yi; Xun Guo; Shuai-Cheng Wu; Yun-Xing Fu; Cui Zhang; Ben-Dong Fu; Hai-Qing Shen; Xu-Bin Wei
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

6.  Role of Suppressor of Cytokine Signaling 3 in the Immune Modulation of Mesenchymal Stromal Cells.

Authors:  Chen Yang; Chunquan Zheng; Hai Lin; Jing Li; Keqing Zhao
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

7.  Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro.

Authors:  H Karlsson; T Erkers; S Nava; S Ruhm; M Westgren; O Ringdén
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

8.  Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

Authors:  Andrea Gray; Rene S Schloss; Martin Yarmush
Journal:  Technology (Singap World Sci)       Date:  2016-09

Review 9.  Specific protein markers for stem cell cross-talk with neighboring cells in the environment.

Authors:  Kyung Soo Park; Seung Won Shin; Jeong-Woo Choi; Soong Ho Um
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

10.  Comparative study of immune regulatory properties of stem cells derived from different tissues.

Authors:  Mariano Di Trapani; Giulio Bassi; Mario Ricciardi; Emanuela Fontana; Francesco Bifari; Luciano Pacelli; Luca Giacomello; Michela Pozzobon; Francois Féron; Paolo De Coppi; Piero Anversa; Guido Fumagalli; Ilaria Decimo; Cedric Menard; Karin Tarte; Mauro Krampera
Journal:  Stem Cells Dev       Date:  2013-08-09       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.